Anpario’s (ANP) House Stock Rating Reiterated at Shore Capital

Shore Capital reissued their house stock rating on shares of Anpario (LON:ANP) in a research note published on Wednesday, Marketbeat.com reports.

Anpario Trading Down 0.8 %

Shares of ANP opened at GBX 322.50 ($4.22) on Wednesday. The company has a current ratio of 5.13, a quick ratio of 5.16 and a debt-to-equity ratio of 0.23. Anpario has a 12-month low of GBX 215 ($2.81) and a 12-month high of GBX 340 ($4.45). The firm has a 50-day moving average price of GBX 290 and a 200 day moving average price of GBX 271.69. The firm has a market capitalization of £54.53 million, a P/E ratio of 2,480.77 and a beta of 0.57.

Anpario Cuts Dividend

The business also recently announced a dividend, which will be paid on Friday, November 29th. Shareholders of record on Thursday, November 14th will be paid a dividend of GBX 3.25 ($0.04) per share. This represents a yield of 1.19%. The ex-dividend date of this dividend is Thursday, November 14th. Anpario’s dividend payout ratio (DPR) is presently 8,461.54%.

Anpario Company Profile

Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.